Brennan to chair PhRMA board, with Kindler waiting in the wings

Share this article:
David Brennan
David Brennan
PhRMA's board of directors elected AstraZeneca chief David Brennan as this year's board chairman and Pfizer chairman and CEO Jeff Kindler chairman-elect. Johnson & Johnson's David Norton, company group chairman, worldwide commercial and operations, Pharmaceuticals Group, was elected board treasurer.

Brennan succeeds Merck president and CEO Richard Clark as PhRMA chairman. The votes came at PhRMA's annual meeting in Washington, DC.

In a statement, Clark said: “The PhRMA member companies accomplished much this pas year. We strengthened our marketing code, tightened our DTC advertising principles and voiced strong support of transparency of company interactions with physicians.”

The agenda for the meeting included discussion of policy issues, including healthcare reform and global intellectual property law, as well as medical innovation.

Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?